Table II.
Clinical patient information in control and patients with chronic lymphocytic leukaemia.
| CLL staging | Control | CLL patients | LN involvement | Spleen involvement | LDH (SD) | B2M (SD) |
|---|---|---|---|---|---|---|
| Binet A | n/a | 14 | 10 | 1 | 157.8±23.99 | 3,444±1546 |
| Binet B | n/a | 15 | 14 | 8 | 199.9±51.53 | 4,671±2187 |
| Binet C | n/a | 19 | 20 | 15 | 231.4±99.64a | 5,169±2915 |
| CLL males | 10 | 23 | ||||
| CLL females | 20 | 25 | ||||
| N | 30 | 48 |
Data are presented as median (interquartile range) or mean ± standard deviation (SD). CLL, chronic lymphocytic leukemia; LDH, lactate dehydrogenase; B2M, β2 microglobulin; LN, lymph node. aP<0.05.